Clinical Trials Browser

Phase 2 × Active not recruiting × Infusions, Intravenous × Clear all

NCT05894889 2025-07-23

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung